Chia-Ing Jan

Title: Chia-Ing Jan: Innovator in Cancer Treatment

Introduction

Chia-Ing Jan is a prominent inventor based in Taichung, Taiwan. He has made significant contributions to the field of cancer treatment through his innovative research and development of chimeric antigen receptors.

Latest Patents

Chia-Ing Jan holds three patents, with his latest inventions focusing on nucleic acids and chimeric antigen receptors. His patents include a chimeric antigen receptor expression plasmid, a chimeric antigen receptor expressing cell, and a pharmaceutical composition for treating cancer. These inventions are designed to specifically target human leukocyte antigen G, which plays a crucial role in immune response. The chimeric antigen receptor expressing cell is created by transducing the receptor into immune cells, enhancing their ability to combat cancer.

Career Highlights

Chia-Ing Jan is affiliated with China Medical University Hospital, where he conducts his research. His work has been instrumental in advancing the understanding and treatment of cancer through innovative therapeutic approaches.

Collaborations

Chia-Ing Jan collaborates with notable colleagues, including Der-Yang Cho and Shao-Chih Chiu, to further enhance the impact of his research in the medical field.

Conclusion

Chia-Ing Jan's contributions to cancer treatment through his patents and research exemplify the importance of innovation in medicine. His work continues to pave the way for new therapeutic strategies that could significantly improve patient outcomes.